Clinical Trials
4 trialsNCT06844669 2026-05-13
HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy
Washington University School of Medicine
Phase 2 Terminated
NCT03879629 2025-11-20
Treating Breast Cancer Patients Undergoing Trastuzumab Treatment With Carvedilol to Reduce Incidence of Heart Failure
Mayo Clinic
Phase 2 Active not recruiting
NCT04023110 2025-10-09
CCTGuide Pilot
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT03418961 2025-10-08
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
SWOG Cancer Research Network
Phase 3 Recruiting